{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Hemodynamic Characteristics of Type II Endoleaks: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Sample size calculation was based on detecting significant differences in TEC parameters, assuming a power of 0.8 and a significance level of 0.05."
      },
      "Participants": {
        "score": 2,
        "evidence": "45 participants at a single center between April 2017 and April 2022."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised into two groups: 20 patients with type II endoleaks identified within 1 week after endovascular aortic repair (EVAR) and 25 patients with persistent type II endoleaks diagnosed during follow-up imaging."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to explore the hemodynamic characteristics of type II endoleaks using mathematical simulations and validate these findings with clinical data from four-dimensional computed tomography (4D-CT)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the consistency between simulation results and clinical time-enhanced curves (TECs) from 4D-CT."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "45 participants at a single center between April 2017 and April 2022."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Significant differences in TEC parameters were observed between stable and enlarged groups, with 80% enhancement duration (AUC, 0.88; sensitivity, 0.87; specificity, 0.80), peak-to-peak time feeder (AUC, 0.78; sensitivity, 0.93; specificity, 0.60), and upslope (AUC, 0.86; sensitivity, 0.73; specificity, 0.93) being most informative."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: None."
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}